Dacarbazine Market Size, Trends Report, Regional Outlook and Forecast to 2034
Dacarbazine, sometimes referred to as DTIC, is a chemotherapeutic drug used to treat several kinds of cancer. It belongs to the triazine family and is categorized as an alkylating agent. It functions by obstructing the proliferation of cancer cells. The medication accomplishes this by damaging DNA, which prevents these cells from replicating and repairing themselves, ultimately resulting in...
0 Comments
0 Shares
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)